Introduction
Shortness of breath and hypoxemia is a common occurrence that may result in a prescription for home oxygen therapy. Long term oxygen therapy (LTOT) has improved survival and exercise tolerance, reduced hospitalizations and enhanced neuropsychological status.2 Home oxygen comprised $2.20 billion of the 2002 Medicare spending for those afflicted by dyspnea and lung-related disability.3 Given the World Health Organization estimates that COPD will be the third most frequent cause of death by 2020, greater worldwide home oxygen therapy is likely. 4 LTOT has been described as constraining thus reducing quality of life for home oxygen users. 2 One study determined that -50% of patients with concentrators remain homebound.5 Yet in another study, chronic obstructive pulmonary disease (COPD) home oxygen users were not limited by stationary oxygen devices but more so by airflow reduction, depression and poor health status. 6 Evaluative comparison of home stationary systems by Kacmarek determined high scores for the oxygen concentrator's usability although problems with delivered oxygen concentration, litre flow and portability were discussed. 7 Tables 1 and 2 . Neither the concentrator nor liquid oxygen delivery units had flow reductions greater than 13.5 and 4.0%, respectively, at 2 L/min and 200 ft (60.96 m) of tubing (Table 1) . Clinically significant drops in flowrate were defined as > 20% reduction in flows which has been discussed as the normal variance for flowmeters.7 In order to determine if the three systems outputs differed, t-tests were conducted between each of the systems. Table 3 gives the t value and the associated P value for each (Figure 3) .
When total flow reductions were averaged from 25 to 200 ft (7.62-60 .96 m) of tubing for each flow setting (Table 2) One explanation for the output flow variations for the three home delivery units through the different lengths of tubing is the operational mechanism and pressure generated by each home oxygen unit. The H cylinder/regulator set up generally operates via a larger pressure difference while the concentrator operates mechanically via generating a moderate pressure. The liquid oxygen system is designed to maintain constant pressure and responses to a small internal pressure difference. As tubing length and flowrate increased, flow reduction was more dramatic with the cylinder/ regulator delivery unit. This is, of course, the original rationale for only supplying the patient with 50 ft (15.24 m) of tubing.
This study is limited to the types of oxygen delivery devices utilized in this study that Manufacturers should determine device performance with varying lengths oftubing and publish the results in the manufacturer's literature. Home care providers and clinicians should query manufacturers regarding home oxygen unit performance with varying tubing lengths. Such data may help to dispel the myth that tubing lengths greater than 50 ft (15.24 m) should never be utilized in the home. Longer tubing lengths may permit more movement and activities to occur in the home setting with oxygen therapy.
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